This guide offers tips for program administrators on developing an effective program for clinical supervision in the substance use disorder treatment field. It addresses cultural competence, and describes supervisor ethics and values.

This guide offers tips for clinical supervisors in the substance use disorder treatment field. It covers functions of a clinical supervisor, and highlights stages of professional development for counselors and clinical supervisors.

This NSDUH report presents results of a survey of illicit substance, alcohol, and tobacco use among people 12 years of age and older. It Includes national estimates of the rates of use, trends, numbers of users, and other measures, such as youth-related prevention measures.

This manual presents guidelines for enhancing motivation among patients in treatment for alcohol and substance misuse. It describes several motivational approaches, ways to integrate these approaches, and two assessment tools.

This manual guides clinicians through stages of primary care for alcohol and substance misuse in adult patients. It discusses warning signs of misuse, screening and follow-up, brief intervention, assessment, treatment models, and legal issues. It includes four screening tools.

This NSDUH report presents national estimates on the prevalence of mental illness and the use mental health services among people ages 12 and older. The report includes data on co-occurring mental illness with substance use.

This report examines trends in illicit substance use from 2010 to 2011 and from 2002 to 2011 among Americans 12 and older, comparing differences by age group and gender. It also discusses disparities in the need for specialized treatment versus those who actually receive it.

This manual offers mental health professionals models and techniques for working with people living with co-occurring disorders. It describes screening and assessment and lists five guiding principles for effective management.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.